Entrapment of ketorolac tromethamine in polymeric vehicle for controlled drug delivery

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 6, 2009, Pages 687-691

  Paliwal, S K ^a   Chauhan, Rajani ^a   Sharma, Veena ^a   Majumdar, D K ^b   Paliwal, S ^c  

^a BANASTHALI UNIVERSITY   (India)

^b DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^c LLRM MEDICAL COLLEGE   (India)

Author keywords

Controlled drug delivery; Corneal permeation; Goat eye; Ketorolac tromethamine; Polymeric vehicle

Indexed keywords

BENZALKONIUM CHLORIDE; CARBOMER; CARBOPOL 934; CARBOXYMETHYLCELLULOSE; EUDRAGIT; EUDRAGIT RS; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC TROMETAMOL;

ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORNEA; CORNEA PERMEABILITY; COW; DIFFUSION CHAMBER; DRUG DELIVERY SYSTEM; DRUG PENETRATION; GOAT; MUCOADHESION; NONHUMAN; SURFACE PROPERTY;

EID: 77249112246     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.59555     Document Type: Article

References (19)

1. Buckley MM, Brogden RN. Ketorolec: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potentials. Drugs 1990;39:86-109.
2. American society of health system. Inc. p.870. ISBN 158528-086-0. Disclaimer 2005.
3. Gillis JC, Brogden RN. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 1997;53:139-188
4. Spickler W. Ketorolac (Toradol): a new analgesic or an old NSAID? Can Med Assoc J 1993;148:1693-1695
5. Lee JW, Park JH, Robison. Bioadhesive-based dosage forms: the next generation. J Pharm Sci 2000;89:850-866
6. Bernkop S, Marcel D. A Mucoadhesive Polymer. In: Dumitriu S. editors. Polymeric Biomaterials. 2nd ed. New York: Marcel Dekker; 2001. p. 47-164.
7. Warkul N, Robbinson J. Drug Delivery by Mucosal Route. In: Dumitriu S, editors. Polymeric Biomaterials. 2nd ed. New York: Marcel Dekker; 2001. p. 1031-1062
8. Peppas N, Huang Y. Nanoscale technology of mucoadhesive interactions. Adv Drug Deliv Rev 2004;56:1675-1687
9. Edsman K, Hagerstorme H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J Pharm Pharmacol 2005;57:3-22.
10. Woodley J. Bioadhesion: New Possibilities for Drug Administration Clin Pharmacokinet 2001;40:77-84.
11. Yamada T, Onishi H, Machida Y. In vitro and in vivo evaluation of sustained release chitosan-coated ketoprofen microparticles. Yakugaku Zasshi 2001;121:239-245 (Pubitemid 32230376)
12. Lim ST, Martin GP, Berry DJ, Brown MB. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 2000;66:81-292.
13. Lehr CM, Bouwstra JA. Schacht EH, Junginger HE. In-vitro evaluation of mucoadhesive properties of chitosan and some others natural polymers. Int J Pharm 1992;78:43-48
14. Jringjai T, Ayumi T, Yohei K, Hirofumi T. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin. J Drug Targeting 2006;14:147-154
15. Franz TH. The Theory and Practice of the Franz Diffusion Cell. In: Current Problems in Dermatology 1978;7:58-68.
16. Pinto R, Neufeld R, Ribeiro A, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine 2006;2:8-21.
17. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. I: in vivo and in vitro kinetics. J Pharm Pharm Sci 1988;77:3-14.
18. Grass GM, Robinson JR. Mechanisms of corneal drug penetration. II: ultra structural analysis of potential pathways for drug movement. J Pharm Pharm Sci 1988;77:15-23.
19. Aurich H, Wirbelauer C, Jaroszewski J, Hartmann C, Pham DT. Continuous measurement of corneal dehydration with online optical coherence pachymetry cornea. Cornea 2006;25:182-184